Effects of D-003 (10 mg / day) and omega-3 fatty acids on the quality of life in postmenopausal women at risk for osteoporosis - D-003/Omega

atural Products Center/ National Center for Scientific Researchs0 个研究点目标入组 50 人开始时间: 2014年8月15日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

研究类型: Interventional
分配方式: Randomized controlled trial. Masking: Double Blind. Control group: Active. Assignment: Parallel. Purpose: Treatment

•1. Healthy female volunteers from common people.
•2. Aged between 20 and 80 years old.
•3. Surgically or naturally postmenopausal (defined as amenorrhea maintained for a period = 1 year).
•4. Risk of osteoporosis moderate to high according to the scale of risk
•5. Which have consented to give their informed consent.

•1. Active liver disease, Active kidney disease, diagnosed Neoplasms or thyroid dysfunction.
•2. Severe high blood pressure (90 mm Hg)
•3. Uncompensated diabetes mellitus (fasting glucose> 7 mmol / L)
•4.Consumption of hormone replacement therapy, bisphosphonates, anabolic steroids, calcitonin, sodium fluoride or corticosteroids in the 6 months prior to inclusion
•5. The following values ??in laboratory tests: fasting glucose> 7 mmol / L; creatinine> 130 mol / L; alanine aminotransferase (ALT) or aspartate aminotransferase (AST)> 55 IU / L
•6. History of acute myocardial infarction (AMI), surgical revascularization or cerebrovascular accident (CVA) (stroke) in the 6 months prior to inclusion.
•7. Subjects with normal clinical history of drug allergy or any other special condition that endanger their health and their lives during the study.

发起方

atural Products Center/ National Center for Scientific Researchs